Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy
<b>Background:</b> Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy. <b>Methods:</b> We conducted a retrospective observational cohort study across 2 tertiary ICUs from September to December 2021. We included all adult patients receiving invasive mechanical ventilation on completion of a 10-day course of dexamethasone for COVID pneumonitis. Our primary outcome was change in P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio in the 7 days following cessation of dexamethasone. Secondary outcomes included duration of ventilation, frequency of corticosteroid recommencement, and mortality. <b>Results:</b> We studied 88 subjects. Median age was 61 years (interquartile range [IQR] 51-67), and median duration of mechanical ventilation was 14 days (IQR 11-26). On completion of dexamethasone, 62 subjects (70%) remained off corticosteroid therapy for the subsequent 7 days. Of these, 63% (<i>n =</i> 20) had a stable P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio on day 7 (mean change 197 ± 42 mm Hg to 258 ± 83 mm Hg). Subjects who had a reduction in P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> ratio >20 mm Hg by day 7 (mean change 214 ± 68 mm Hg to 152 ± 78 mm Hg) were more likely to die in hospital (<i>P</i> < .001). These subjects had a higher C-reactive protein level at time of steroid cessation (204 ± 87 mg/L, <i>P</i> = .17), which remained persistently elevated (206 ± 89 mg/L, <i>P</i> = .01) on day 7. The 30% of subjects who recommenced steroids required a longer duration of ventilation (13.5 vs 24.5 d, <i>P</i> = .002) but showed no differences in ICU mortality (19% vs 27%, <i>P</i> = .43). <b>Conclusions:</b> Rebound hypoxemia and steroid recommencement were common occurrences in mechanically ventilated subjects with COVID-19. Rebound hypoxemia was associated with higher mortality. Steroid recommencement was associated with longer duration of mechanical ventilation but no significant difference in mortality.
Authors
- Hannah Rotherham (ORCID: https://orcid.org/0000-0002-8247-5223)
- Rahul Costa‐Pinto (ORCID: https://orcid.org/0000-0003-4007-7849)
- Rinaldo Bellomo (ORCID: https://orcid.org/0000-0002-1650-8939)
- Padeepa Perera (ORCID: https://orcid.org/0000-0002-1348-5911)
- Zachary O’Brien
- Vicky Chen (ORCID: https://orcid.org/0000-0003-4595-154X)
- Bing Xu
- Christopher Massarany
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Austin Hospital (AU)
- Australian and New Zealand Intensive Care Society (AU)
- Royal Dental Hospital of Melbourne (AU)
Publication Details
- Journal
- Respiratory Care
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1089/respcare.12494
- Primary Topic
- Thermal Regulation in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00